review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Cristina Cunha | Q47314450 |
Agostinho Carvalho | Q47504201 | ||
Katrien Lagrou | Q50099914 | ||
Samuel M Gonçalves | Q59670718 | ||
Cláudio Duarte-Oliveira | Q60364489 | ||
P2093 | author name string | Johan A Maertens | |
P2860 | cites work | The microbiome of the lung | Q24602074 |
Compartmentalized control of skin immunity by resident commensals | Q24603475 | ||
The skin microbiome | Q24634180 | ||
A homozygous CARD9 mutation in a family with susceptibility to fungal infections | Q24658090 | ||
The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus | Q24811208 | ||
Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation | Q42230664 | ||
Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation | Q42851594 | ||
Editorial overview: host-microbe interactions: fungi: heterogeneity in fungal cells, populations, and communities | Q43159103 | ||
Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections | Q43593080 | ||
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study | Q43631437 | ||
Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice | Q44086922 | ||
Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. | Q45760347 | ||
Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum | Q46277042 | ||
Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation | Q46539385 | ||
Host-microorganism interactions in lung diseases | Q46810894 | ||
Sputum microbiota in moderate versus severe patients with COPD. | Q46962967 | ||
Aspergillosis | Q55951920 | ||
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity | Q58855374 | ||
PTX3-Based Genetic Testing for Risk of Aspergillosis After Lung Transplant: Table 1 | Q60451853 | ||
Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice | Q82703707 | ||
Regulation of lung immunity and host defense by the intestinal microbiota | Q26779232 | ||
Control of pathogens and pathobionts by the gut microbiota | Q27013060 | ||
Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis | Q28081259 | ||
Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
Genetic variation in Toll-like receptors and disease susceptibility | Q28267031 | ||
Duodenal infusion of donor feces for recurrent Clostridium difficile | Q28283517 | ||
The gut microbiota--masters of host development and physiology | Q28286102 | ||
Invasive aspergillosis in the intensive care unit | Q28306909 | ||
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 | ||
IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis | Q28534626 | ||
Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation | Q28551061 | ||
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management | Q28730299 | ||
Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome | Q28829667 | ||
Modulation of potential respiratory pathogens by pH1N1 viral infection. | Q30423825 | ||
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | Q31144277 | ||
The interplay between the innate immune system and the microbiota | Q31151778 | ||
PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition | Q33632044 | ||
The changing microbial epidemiology in cystic fibrosis | Q33825634 | ||
Deep dermatophytosis and inherited CARD9 deficiency | Q33855073 | ||
The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography | Q33901596 | ||
Reciprocal interactions of the intestinal microbiota and immune system. | Q34033579 | ||
Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection | Q34182454 | ||
The role of the microbiome in exacerbations of chronic lung diseases | Q34199591 | ||
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients | Q34406338 | ||
Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts | Q34412019 | ||
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. | Q34518423 | ||
Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation | Q34533098 | ||
Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis | Q34536205 | ||
Human genetics shape the gut microbiome. | Q34630305 | ||
The emerging world of the fungal microbiome | Q34727901 | ||
Microbiota regulates immune defense against respiratory tract influenza A virus infection | Q34750186 | ||
The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis | Q34772679 | ||
Human genetic susceptibility to invasive aspergillosis | Q34945368 | ||
A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. | Q35001502 | ||
A risk prediction score for invasive mold disease in patients with hematological malignancies | Q35005712 | ||
A breath fungal secondary metabolite signature to diagnose invasive aspergillosis | Q35029333 | ||
Application of a neutral community model to assess structuring of the human lung microbiome | Q35072309 | ||
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
The lung mycobiome: an emerging field of the human respiratory microbiome. | Q35082308 | ||
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes | Q35131913 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals | Q35172371 | ||
The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease | Q35277785 | ||
Topographical continuity of bacterial populations in the healthy human respiratory tract | Q35528519 | ||
Functional analysis of cilia and ciliated epithelial ultrastructure in healthy children and young adults | Q35535836 | ||
The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease | Q35687192 | ||
The Gut-Lung Axis in Respiratory Disease | Q35848701 | ||
Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses | Q35880265 | ||
Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells | Q35895198 | ||
Biogeography of a human oral microbiome at the micron scale | Q35904645 | ||
Enhancement of Microbiota in Healthy Macaques Results in Beneficial Modulation of Mucosal and Systemic Immune Function | Q35908830 | ||
Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity | Q35922452 | ||
Lung microbiome dynamics in COPD exacerbations | Q35936580 | ||
Does the microbiota regulate immune responses outside the gut? | Q35946273 | ||
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications | Q35987288 | ||
The evolution of cooperation within the gut microbiota. | Q35998247 | ||
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity | Q36002388 | ||
The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites | Q36041507 | ||
The microbiome and innate immunity | Q36069070 | ||
Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis | Q36204582 | ||
Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. | Q36344062 | ||
Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease | Q36390314 | ||
Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. | Q36614277 | ||
Commensal bacteria calibrate the activation threshold of innate antiviral immunity | Q36921389 | ||
Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome | Q37018586 | ||
Comparison of the respiratory microbiome in healthy nonsmokers and smokers | Q37073006 | ||
Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. | Q37229478 | ||
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands | Q37380370 | ||
Role of antibiotics and fungal microbiota in driving pulmonary allergic responses | Q37521749 | ||
Epidemiology of invasive mycoses in North America | Q37678397 | ||
Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. | Q37717451 | ||
Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens | Q38025737 | ||
Microbiota abnormalities in inflammatory airway diseases - Potential for therapy | Q38130813 | ||
Innate lymphoid cells and asthma | Q38200228 | ||
Host genetics of invasive Aspergillus and Candida infections | Q38268925 | ||
Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. | Q38311200 | ||
Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation | Q38578579 | ||
GPR43 - A Prototypic Metabolite Sensor Linking Metabolic and Inflammatory Diseases | Q38594132 | ||
Aspergillus infections in cystic fibrosis | Q38833989 | ||
Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions | Q38843831 | ||
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease | Q38853672 | ||
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs | Q38882885 | ||
Volatile Compounds Emitted by Pseudomonas aeruginosa Stimulate Growth of the Fungal Pathogen Aspergillus fumigatus | Q39486474 | ||
Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. | Q39488014 | ||
Microbial Biofilms in Pulmonary and Critical Care Diseases. | Q40635408 | ||
Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation | Q40787967 | ||
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management | Q40859210 | ||
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis | Q40974392 | ||
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity | Q41171975 | ||
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant | Q41228764 | ||
The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. | Q41812432 | ||
P433 | issue | 6 | |
P921 | main subject | microbiome | Q1330402 |
P304 | page(s) | 673-684 | |
P577 | publication date | 2016-11-07 | |
P1433 | published in | Virulence | Q18712614 |
P1476 | title | The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases | |
P478 | volume | 8 |
Search more.